In the News

November 22nd, 2021

Shear Insights: HemoShear to be Featured at International Metabolic Conference

Read More »
November 2nd, 2021

Shear Insights: HemoShear Therapeutics Appoints Organizational Development Leader and Recruiter as Company Grows

Read More »
August 4th, 2021

Shear Insights: Brian Wamhoff Recognized as one of the PharmaVOICE 100 Most Inspiring People

Read More »
May 3rd, 2021

Shear Insights: Peer-Reviewed Journal Publishes the Discovery of HemoShear’s HST5040 Small Molecule in Clinical Development for Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA)

Read More »
February 22nd, 2021

BioCentury: $40M series A sets up HemoShear to complete evolution from service play to clinical-stage biotech 

Read More »
January 28th, 2021

HemoShear announces appointment of Vice Presidents

Read More »
November 30th, 2020

Shear Insights: HemoShear Therapeutics to Present at Piper Sandler Annual Healthcare Conference

Read More »
November 12th, 2020

Shear Insights: HemoShear Therapeutics Launches Pilot Study to Evaluate Neuropsychological Assessments for MMA and PA

Read More »
September 29th, 2020

Shear Insights: Mavis Waller Appointed to Vice President, Clinical Operations as HemoShear Readies for Clinical Trials

Read More »
August 25th, 2020

HemoShear Therapeutics featured as NIH Small Business Innovation Research Grant Success Story

Read more at SBIR/STTR
August 10th, 2020

HemoShear to Present at Upcoming Investor Conferences

Read More »
June 4th, 2020

Shear Insights: Journal Publishes HemoShear Models for Rare Metabolic Diseases

Read More »
View More +


HemoShear Therapeutics, Inc.
501 Locust Avenue
Suite 301
Charlottesville, Virginia 22902